Balance Sheet
Cash Flow Statement
Growth Metrics
Income Statement
Consolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Equity IncomeGross ProfitIncome from Continuing OperationsIncome from Non-Controlling InterestsIncome towards Parent CompanyNet Income - MinorityNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

Teva Pharmaceutical Industries (TEVJF) Preferred Dividend Payments (2016 - 2018)

Historic Preferred Dividend Payments for Teva Pharmaceutical Industries (TEVJF) over the last 4 years, with Q4 2018 value amounting to $54.0 million.

  • Teva Pharmaceutical Industries' Preferred Dividend Payments fell 1692.31% to $54.0 million in Q4 2018 from the same period last year, while for Dec 2018 it was $249.0 million, marking a year-over-year decrease of 423.08%. This contributed to the annual value of $249.0 million for FY2018, which is 423.08% down from last year.
  • Teva Pharmaceutical Industries' Preferred Dividend Payments amounted to $54.0 million in Q4 2018, which was down 1692.31% from $65.0 million recorded in Q3 2018.
  • Teva Pharmaceutical Industries' Preferred Dividend Payments' 5-year high stood at $66000.0 billion during Q2 2016, with a 5-year trough of $15.0 million in Q4 2015.
  • Its 4-year average for Preferred Dividend Payments is $10000.1 billion, with a median of $65.0 million in 2016.
  • Per our database at Business Quant, Teva Pharmaceutical Industries' Preferred Dividend Payments soared by 33333.33% in 2016 and then plummeted by 9999.99% in 2017.
  • Quarter analysis of 4 years shows Teva Pharmaceutical Industries' Preferred Dividend Payments stood at $15.0 million in 2015, then soared by 333.33% to $65.0 million in 2016, then changed by 0.0% to $65.0 million in 2017, then decreased by 16.92% to $54.0 million in 2018.
  • Its last three reported values are $54.0 million in Q4 2018, $65.0 million for Q3 2018, and $65.0 million during Q2 2018.